Glucose and metabolic health
Glucose and metabolic health markers
Goal tierNot rated yet
No direct evidence for general supplement use is confirmed under the current standard.
Check this goal in more detailPublic-ready7/5/2026
Glycine
Papers analyzed
93
Glucose and metabolic health markersBlood pressure and vascular health markersExercise performance and recovery
Main benefit evidence
Review human evidence by goal.
Blood pressure and vascular health
Blood pressure and vascular health markers
Goal tierNot rated yet
The currently linked research coverage is not broad enough to characterize this goal yet.
Check this goal in more detailExercise performance and recovery
Exercise performance and recovery
Goal tierNot rated yet
The currently linked research coverage is not broad enough to characterize this goal yet.
Check this goal in more detailSleep
Stress Response and Sleep Changes
Goal tierNot rated yet
The currently linked research coverage is not broad enough to characterize this goal yet.
Check this goal in more detailSide effects and combination findings in studies
Findings from studies of this ingredient alone are separated from findings involving another supplement or medication.
Caution signals
0
Side effects + combos + curated rules
Key precautions
No combination caution signal is clear enough to show right now. This does not guarantee safety.
1 combo signals and 0 added-signal combos shown below.
These are signals reported in studies. They do not predict what will happen to an individual.
Positive combinations studied
Positive combination findings are separated by how the study compared the groups. This is not a recommendation to combine them.
Positive findings when used together
The combination had a positive result, but the contribution of each ingredient could not be separated.
NACIn a randomized clinical trial of older adults, GlyNAC (a combination of glycine and NAC) supplementation for 16 weeks improved glutathione deficiency, oxidative stress, and mitochondrial dysfunction compared to placebo.
Glycine
arrow_backBack to list